182 related articles for article (PubMed ID: 24397848)
1. Structural basis of Mos1 transposase inhibition by the anti-retroviral drug Raltegravir.
Wolkowicz UM; Morris ER; Robson M; Trubitsyna M; Richardson JM
ACS Chem Biol; 2014 Mar; 9(3):743-51. PubMed ID: 24397848
[TBL] [Abstract][Full Text] [Related]
2. A Mos1 transposase in vivo assay to screen new HIV-1 integrase inhibitors.
Cancian M; Loreto ELS
Genetica; 2018 Apr; 146(2):243-247. PubMed ID: 29352755
[TBL] [Abstract][Full Text] [Related]
3. Comparison of raltegravir and elvitegravir on HIV-1 integrase catalytic reactions and on a series of drug-resistant integrase mutants.
Marinello J; Marchand C; Mott BT; Bain A; Thomas CJ; Pommier Y
Biochemistry; 2008 Sep; 47(36):9345-54. PubMed ID: 18702518
[TBL] [Abstract][Full Text] [Related]
4. Solution conformations of early intermediates in Mos1 transposition.
Cuypers MG; Trubitsyna M; Callow P; Forsyth VT; Richardson JM
Nucleic Acids Res; 2013 Feb; 41(3):2020-33. PubMed ID: 23262225
[TBL] [Abstract][Full Text] [Related]
5. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization and comparison of two closely related active mariner transposases.
Trubitsyna M; Morris ER; Finnegan DJ; Richardson JM
Biochemistry; 2014 Feb; 53(4):682-9. PubMed ID: 24404958
[TBL] [Abstract][Full Text] [Related]
7. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance.
Hare S; Vos AM; Clayton RF; Thuring JW; Cummings MD; Cherepanov P
Proc Natl Acad Sci U S A; 2010 Nov; 107(46):20057-62. PubMed ID: 21030679
[TBL] [Abstract][Full Text] [Related]
8. Molecular architecture of the Mos1 paired-end complex: the structural basis of DNA transposition in a eukaryote.
Richardson JM; Colloms SD; Finnegan DJ; Walkinshaw MD
Cell; 2009 Sep; 138(6):1096-108. PubMed ID: 19766564
[TBL] [Abstract][Full Text] [Related]
9. Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.
Johnson BC; Métifiot M; Pommier Y; Hughes SH
Antimicrob Agents Chemother; 2012 Jan; 56(1):411-9. PubMed ID: 22037850
[TBL] [Abstract][Full Text] [Related]
10. Consensus HIV-1 subtype A integrase and its raltegravir-resistant variants: design and characterization of the enzymatic properties.
Shadrina O; Krotova O; Agapkina J; Knyazhanskaya E; Korolev S; Starodubova E; Viklund A; Lukashov V; Magnani M; Medstrand P; Karpov V; Gottikh M; Isaguliants M
Biochimie; 2014 Jul; 102():92-101. PubMed ID: 24594066
[TBL] [Abstract][Full Text] [Related]
11. Structural role of the flanking DNA in mariner transposon excision.
Dornan J; Grey H; Richardson JM
Nucleic Acids Res; 2015 Feb; 43(4):2424-32. PubMed ID: 25662605
[TBL] [Abstract][Full Text] [Related]
12. HIV integrase inhibitor, Elvitegravir, impairs RAG functions and inhibits V(D)J recombination.
Nishana M; Nilavar NM; Kumari R; Pandey M; Raghavan SC
Cell Death Dis; 2017 Jun; 8(6):e2852. PubMed ID: 28569776
[TBL] [Abstract][Full Text] [Related]
13. Structural Basis for the Inverted Repeat Preferences of mariner Transposases.
Trubitsyna M; Grey H; Houston DR; Finnegan DJ; Richardson JM
J Biol Chem; 2015 May; 290(21):13531-40. PubMed ID: 25869132
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of the integrase-DNA complex by Mg2+ ions and prediction of key residues for binding HIV-1 integrase inhibitors.
Miri L; Bouvier G; Kettani A; Mikou A; Wakrim L; Nilges M; Malliavin TE
Proteins; 2014 Mar; 82(3):466-78. PubMed ID: 24038133
[TBL] [Abstract][Full Text] [Related]
15. Comparative architecture of transposase and integrase complexes.
Rice PA; Baker TA
Nat Struct Biol; 2001 May; 8(5):302-7. PubMed ID: 11774877
[TBL] [Abstract][Full Text] [Related]
16. Comparative architecture of transposase and integrase complexes.
Rice PA; Baker TA
Nat Struct Biol; 2001 Apr; 8(4):302-7. PubMed ID: 11276247
[TBL] [Abstract][Full Text] [Related]
17. First Mariner Mos1 transposase inhibitors.
Bouchet N; Bischerour J; Germon S; Guillard J; Dubernet M; Viaud-Massuard MC; Delelis O; Ryabinin V; Bigot Y; Augé-Gouillou C
Mini Rev Med Chem; 2009 Apr; 9(4):431-9. PubMed ID: 19356121
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of Mos1 transposition: insights from structural analysis.
Richardson JM; Dawson A; O'Hagan N; Taylor P; Finnegan DJ; Walkinshaw MD
EMBO J; 2006 Mar; 25(6):1324-34. PubMed ID: 16511570
[TBL] [Abstract][Full Text] [Related]
19. Integrase illuminated.
Cherepanov P
EMBO Rep; 2010 May; 11(5):328. PubMed ID: 20428106
[TBL] [Abstract][Full Text] [Related]
20. A bend, flip and trap mechanism for transposon integration.
Morris ER; Grey H; McKenzie G; Jones AC; Richardson JM
Elife; 2016 May; 5():. PubMed ID: 27223327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
